We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current METXF market cap is 74.24M. The company's latest EPS is CAD -0.0514 and P/E is -57.39.
| Year End 31 August 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -70k | -640k | -1.37M |
| Net Income | -145k | -6.52M | -1.3M |
| Year End 31 August 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 102k | 672k | 1.54M |
| Total Liabilities | 233k | 149k | 63k |
| Total Equity | -131k | 523k | 1.48M |
| Year End 31 August 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Operating | -136k | -303k | -658k |
| Investing | N/A | 757k | N/A |
| Financing | 140k | 116k | 1.51M |
| Market Cap | 74.24M |
| Price to Earnings Ratio | -57.39 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 49.66 |
| Price to Book Ratio | 50.34 |
| Dividend Yield | - |
| Shares Outstanding | 25.19M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 2.9474 |
| 52 Week Low | 2.9474 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Me Therapeutics Holdings Inc (PK) |
| Address |
177 robson street vancouver, british columbia V6B 0N3 |
| Website | https://www.metherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
